Evidence map›Paper›PMID 40686863›Full record

ArticleFood chemistry: X2025

Production of soy aglycones as an alternative estrogen via innovative synergy of commercial and novel

Hyeon-Jun Seong, Deepti Bharti, Seong Gyung Kim, Kwang-Yeol Yang, Seung-Hee Nam

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Food chemistry: X, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hyeon-Jun SeongDepartment of Integrative Food, Bioscience, and Biotechnology, Chonnam National University, Gwangju 61186, South Korea.
Deepti BhartiDepartment of Integrative Food, Bioscience, and Biotechnology, Chonnam National University, Gwangju 61186, South Korea.
Seong Gyung KimDepartment of Integrative Food, Bioscience, and Biotechnology, Chonnam National University, Gwangju 61186, South Korea.
Kwang-Yeol YangDepartment of Applied Biology, College of Agriculture and Life Sciences, Chonnam National University, Gwangju 61186, South Korea.
Seung-Hee NamDepartment of Integrative Food, Bioscience, and Biotechnology, Chonnam National University, Gwangju 61186, South Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Soy isoflavones help mitigate cancer and estrogen-related diseases. This study aimed to improve raw soybean functionality by optimizing enzymatic biotransformation to produce soy aglycones, primarily daidzein and genistein, which resemble endogenous estrogen. Initial screening optimized commercial and fermented food-derived enzymes to boost isoflavone and aglycone content, respectively. The sequential application of Pluszyme 2000P© and

Indexed as

DeglycosylationEstrogenIsoflavoneSoybeanΒ-Glucosidase

Identifiers

PMID40686863
PMCPMC12272626

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.